Search

everythinglearnresearchcommunity

for

Search:↓

The user experienced positive hair regrowth using daily 1mg finasteride and 5% minoxidil, specifically the Alopexy brand, with no negative side effects. They noticed improvements after a year, with comments from others confirming the success.

A user shared their 4-year progress using topical minoxidil and 1mg finasteride daily for hair regrowth, noting plans to reduce finasteride due to minor side effects. They emphasized consistency as key to success, with noticeable improvements in hair density and color.

Dutasteride is effective for many in reducing hair loss and promoting regrowth, often with fewer side effects than finasteride. Combining it with minoxidil is commonly seen as a successful strategy, though results may take several months.

The conversation discusses a hair loss treatment regimen involving dutasteride, pyrilutamide, oral minoxidil, and microneedling, with the aim of suppressing DHT and stimulating hair growth. Users debate the effectiveness and potential side effects of these treatments, noting that individual results may vary and that no treatment is foolproof.

The conversation discusses whether to continue using finasteride or switch to dutasteride after one year, with users generally advising to stick with finasteride for more time due to positive results and potential risks of switching. Minoxidil is also being used, and some suggest considering a hair transplant for further improvement.

A 21-year-old male uses minoxidil, finasteride, and dutasteride for hair loss but still experiences progression with high DHT levels. Suggestions include increasing dosages, checking for deficiencies, considering a hair system, or consulting a specialist.

PP405 is a potential hair loss treatment, but its safety and effectiveness are uncertain. Users advise caution and suggest waiting for more data before purchasing unverified versions.

The user has been using finasteride and minoxidil for 11 months but is experiencing increased hair loss and no signs of improvement. Another user shares a similar experience and mentions iron deficiency and thyroid issues affecting hair loss despite using the treatments.

The user experienced significant hair loss after stopping a treatment of 5% Minoxidil and 0.1% Finasteride, which they had used from December 2021 to January 2024. They resumed the treatment in April 2025, hoping for regrowth, and are considering additional treatments like transplants and steroid injections.

The user experienced significant hair regrowth after one year of using oral minoxidil (2.5mg) and oral finasteride (1mg), with no side effects except initial shedding. The user noticed thicker eyebrows and beard, and the hairline improved with baby hairs, but the hair quality differs from the rest of the head.

The user experienced noticeable hair regrowth after three months of using topical minoxidil and finasteride, with no reported side effects. Other users discussed their experiences with similar treatments, including concerns about side effects and alternative options like dutasteride.

PP405 shows potential for hair growth, with 31% of advanced balding men experiencing over 20% increase in hair density in 8 weeks. However, skepticism persists due to selective data presentation and lack of long-term results, with comparisons to treatments like minoxidil and finasteride.

PP405 is seen as promising but uncertain, with users advised to continue using existing treatments like minoxidil and finasteride. Concerns include its cost, availability, and interaction with hair transplants, while some hope it could complement current treatments.

Switching to Dutasteride worsened hair condition, causing shedding and inflammation. The user will continue Dutasteride until 18 months before possibly switching back to Finasteride, while using oral Minoxidil.

The conversation discusses the use of topical spironolactone for hair loss, with the original poster applying 8 ml daily but learning that 2 ml is recommended. It also touches on hair transplants and the role of DHT sensitivity in hair loss, emphasizing individual differences in treatment outcomes.

Finasteride and Dutasteride will remain accessible in the EU despite objections from France and Belgium. Users discuss the ease of obtaining these medications in different countries and express relief and support for the EU's decision.

PP405 shows promise in hair regrowth, with 31% of participants experiencing over 20% increase in hair density after 8 weeks. Phase 3 trials are expected in 2026, with potential market availability by 2029-2031.

Ketoconazole shampoo may reduce scalp DHT by around 10% but is not effective enough to stop hair loss on its own. For better results, finasteride, minoxidil, and lifestyle changes are recommended.

The conversation is about a user's hair transformation using a routine that included dermastamping, minoxidil, finasteride, ketoconazole, and rosemary oil. The user later stopped using minoxidil and rosemary oil due to greasiness, continuing with finasteride, dermastamping, and ketoconazole.

A 27-year-old male with diffuse hair loss, including the donor area, did not respond to finasteride, dutasteride, or minoxidil. He suspects his hair loss may be linked to a mild connective tissue disorder, possibly affecting the structural support of hair follicles, rather than being purely hormonal.

A 23-year-old male experienced initial success with finasteride, topical minoxidil, and ketoconazole for hair loss, but persistent shedding and scalp issues led him to switch to dutasteride without improvement. Users suggest stress management, addressing potential seborrheic dermatitis, and patience with the treatment process.

A user reported positive hair regrowth using finasteride and minoxidil for 2 months, noting thicker roots and improved appearance. The post led to skepticism and discussions on treatment methods and side effects.

After 8 months on finasteride, the user experiences increased hair shedding and thinning, despite also using minoxidil and microneedling. They consider switching to dutasteride but decide to continue the current regimen for a year before reassessing.

A 27-year-old has been using finasteride for nearly a year and minoxidil since December 2024, experiencing initial improvement but recent hair loss again. They are considering microneedling and are concerned about the stability of their hair condition, with stress and other factors potentially affecting results.

The user is experiencing hair loss and is concerned about a small bald patch despite having thick hair and a full crown. They are considering starting minoxidil and finasteride to prevent further hair loss.

A user shared their two-year progress using finasteride 1mg daily for hair recovery, noting significant improvement with minimal side effects like a slight decrease in libido. They initially tried microneedling weekly for six months but discontinued it, and they are now experimenting with reducing the finasteride dose to 0.5mg daily.

Finasteride is recommended for hair loss starting at age 17, with some users suggesting starting even earlier. Minoxidil is also suggested as an option, while lifestyle changes like diet and exercise are noted as beneficial for health but not effective for slowing genetic hair loss.

A 30-year-old woman with a history of anemia and low vitamin D experienced hair shedding, which improved after addressing nutrient deficiencies. Despite regrowth of terminal hairs, her dermatologist recommended treatments like minoxidil and spironolactone to prevent future bald spots, but she is cautious due to family history of hormone-related cancers.

OP experienced significant hair regrowth with Dutasteride over three years but recently faced a massive hair shed, raising concerns about the medication's effectiveness. OP has not used Minoxidil.

A user shared their hair loss journey using oral finasteride for over six years and oral minoxidil for one year, noting some progress and considering switching to dutasteride. Others shared mixed results and side effects from using minoxidil, finasteride, and dutasteride.